We are live on
!
Find out more
SCM
Sigma Capital Management Portfolio holdings
AUM
$1.95B
1-Year Est. Return
42.86%
This Fund
S&P 500
This Quarter
Est. Return
+7.72%
1 Year Est. Return
+42.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
–
Cap. Flow
+$2.15B
Cap. Flow
% of AUM
98.79%
Top 10 Holdings %
Top 10 Hldgs %
21.71%
Holding
235
New
235
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$59.7M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
HOUS
Anywhere Real Estate
HOUS
|
+$47.3M |
| 4 |
Eagle Materials
EXP
|
+$45.7M |
| 5 |
GNC
GNC Holdings, Inc.
GNC
|
+$45.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 31.78% |
| 2 | Energy | 14.08% |
| 3 | Industrials | 7.32% |
| 4 | Healthcare | 6.13% |
| 5 | Technology | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
Patterson-UTI
PTEN
$3.62B
| $2.9M | 0.13% |
+150,000
| New | +$3.27M |
|
152
Magna International
MGA
$18B
| $2.82M | 0.13% |
+79,172
| New | +$2.51M |
|
153
Lam Research
LRCX
$356B
| $2.79M | 0.13% |
+630,000
| New | +$2.85M |
|
|
RDC
154
DELISTED
Rowan Companies Plc
RDC
| $2.73M | 0.13% |
+80,000
| New | +$2.69M |
|
155
Analog Devices
ADI
$179B
| $2.7M | 0.12% |
+60,000
| New | +$2.7M |
|
156
Copa Holdings
CPA
$5.6B
| $2.7M | 0.12% |
+20,614
| New | +$2.63M |
|
|
PACT
157
DELISTED
PACTERA TECHNOLOGY INTL LTD SPONSORED ADR
PACT
| $2.7M | 0.12% |
+400,000
| New | +$2.42M |
|
158
Neurocrine Biosciences
NBIX
$17.8B
| $2.68M | 0.12% |
+200,000
| New | +$2.46M |
|
159
Eaton
ETN
$153B
| $2.65M | 0.12% |
+40,248
| New | +$2.54M |
|
|
TRNX
160
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $2.63M | 0.12% |
+150,000
| New | +$2.58M |
|
|
STML
161
DELISTED
Stemline Therapeutics, Inc.
STML
| $2.62M | 0.12% |
+110,000
| New | +$1.75M |
|
162
Sanofi
SNY
$106B
| $2.58M | 0.12% |
+50,000
| New | +$2.66M |
|
|
ECHO
163
EchoStar
ECHO
$25B
| $2.57M | 0.12% |
+80,990
| New | +$2.57M |
|
|
MNTA
164
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.56M | 0.12% |
+170,000
| New | +$2.24M |
|
165
Humana
HUM
$46.2B
| $2.53M | 0.12% |
+30,000
| New | +$2.37M |
|
166
Elevance Health
ELV
$82.2B
| $2.46M | 0.11% |
+30,000
| New | +$2.25M |
|
167
Marvell Technology
MRVL
$168B
| $2.45M | 0.11% |
+209,000
| New | +$2.27M |
|
|
XLNX
168
DELISTED
Xilinx Inc
XLNX
| $2.38M | 0.11% |
+59,984
| New | +$2.3M |
|
|
ROSE
169
DELISTED
ROSETTA RESOURCES INC
ROSE
| $2.37M | 0.11% |
+55,800
| New | +$2.55M |
|
|
EMC
170
DELISTED
EMC CORPORATION
EMC
| $2.36M | 0.11% |
+100,000
| New | +$2.36M |
|
171
NXP Semiconductors
NXPI
$66.7B
| $2.32M | 0.11% |
+74,920
| New | +$2.19M |
|
|
EQC
172
CALL
DELISTED
Equity Commonwealth
EQC
| $2.31M | 0.11% |
+100,000
| New | +$2.16M |
|
173
WEX
WEX
$6.14B
| $2.3M | 0.11% |
+30,000
| New | +$2.23M |
|
174
CVS Health
CVS
$137B
| $2.29M | 0.1% |
+40,000
| New | +$2.32M |
|
175
Regeneron Pharmaceuticals
REGN
$70.6B
| $2.25M | 0.1% |
+10,000
| New | +$2.33M |
|
Similar funds
SZC
CII
HOAM
SC
G
TT
IPRC
EP
Sigma Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Sigma Capital Management, which disclosed 235 positions worth $2.18B. Its ten largest holdings account for 22% of the portfolio.
Its largest position is EOG Resources: 931,476 shares worth $61.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, followed by Energy and Industrials.
- Sigma Capital Management's largest Q2 2013 buy was EOG Resources: 931,476 shares worth $61.3M.
- Sigma Capital Management's ten largest holdings make up 22% of its $2.18B portfolio in Q2 2013.
- Sigma Capital Management disclosed 235 positions in Q2 2013, its first 13F filing on record.
Based on Sigma Capital Management's 13F filing for Q2 2013, filed 15 Aug 2013.